247 related articles for article (PubMed ID: 2476135)
1. Tissue selective inhibition of cyclic nucleotide phosphodiesterase by denbufylline.
Wilke R; Arch JR; Nicholson CD
Arzneimittelforschung; 1989 Jun; 39(6):665-7. PubMed ID: 2476135
[TBL] [Abstract][Full Text] [Related]
2. The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site.
Nicholson CD; Jackman SA; Wilke R
Br J Pharmacol; 1989 Jul; 97(3):889-97. PubMed ID: 2474352
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo inhibitory effects of propentofylline on cyclic AMP phosphodiesterase activity.
Nagata K; Ogawa T; Omosu M; Fujimoto K; Hayashi S
Arzneimittelforschung; 1985; 35(7):1034-6. PubMed ID: 2996562
[TBL] [Abstract][Full Text] [Related]
4. 8-phenyltheophylline as an inhibitor of cyclic AMP hydrolysis by cyclic nucleotide phosphodiesterase.
Nicholson CD; Wilke R
J Auton Pharmacol; 1989 Jun; 9(3):159-65. PubMed ID: 2545716
[TBL] [Abstract][Full Text] [Related]
5. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
Miot F; Erneux C; Wells JN; Dumont JE
Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
Kumari M; Cover PO; Poyser RH; Buckingham JC
Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
[TBL] [Abstract][Full Text] [Related]
7. The inhibition by xanthine phosphodiesterase inhibitors of the induction of alkaline phosphatase activity in HeLa cells: relationship of enzyme activity to cyclic AMP concentrations.
Wharton W; Goz B
J Cell Physiol; 1979 Sep; 100(3):509-18. PubMed ID: 90681
[TBL] [Abstract][Full Text] [Related]
8. Effects of the new phosphodiesterase inhibitor griseolic acid on insulin release in rat pancreatic islets.
Hashimoto N; Makino H; Kanatsuka A; Yamazaki M; Yoshida S
Arzneimittelforschung; 1990 Oct; 40(10):1098-101. PubMed ID: 1705426
[TBL] [Abstract][Full Text] [Related]
9. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
Rose RJ; Liu H; Palmer D; Maurice DH
Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of fibroblast cyclic AMP escape and cyclic nucleotide phosphodiesterase activities by xanthines.
Nemecek GM; Wells JN; Butcher RW
Mol Pharmacol; 1980 Jul; 18(1):57-64. PubMed ID: 6251359
[No Abstract] [Full Text] [Related]
11. The low KM-phosphodiesterase inhibitor denbufylline enhances neuronal excitability in guinea pig hippocampus in vitro.
Sutor B; Alzheimer C; Ameri A; ten Bruggencate G
Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):349-56. PubMed ID: 1704105
[TBL] [Abstract][Full Text] [Related]
12. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
13. Effect of different xanthines and phosphodiesterase inhibitors on c-fos expression in rat striatum.
Svenningsson P; Johansson B; Fredholm BB
Acta Physiol Scand; 1995 May; 154(1):17-24. PubMed ID: 7572198
[TBL] [Abstract][Full Text] [Related]
14. Modulation of carbachol-induced inositol phosphate formation in bovine tracheal smooth muscle by cyclic AMP phosphodiesterase inhibitors.
Hall IP; Donaldson J; Hill SJ
Biochem Pharmacol; 1990 Apr; 39(8):1357-63. PubMed ID: 1690998
[TBL] [Abstract][Full Text] [Related]
15. Relaxant effects of various xanthine derivatives. Relationship to cyclic nucleotide phosphodiesterase inhibition.
Takagi K; Ogawa K; Tanaka H; Satake T; Watanabe Y; Chijiwa T; Hidaka H
Adv Second Messenger Phosphoprotein Res; 1992; 25():353-62. PubMed ID: 1313267
[No Abstract] [Full Text] [Related]
16. OPC-13013, a cyclic nucleotide phosphodiesterase type III, inhibitor, inhibits cell proliferation and transdifferentiation of cultured rat hepatic stellate cells.
Shimizu E; Kobayashi Y; Oki Y; Kawasaki T; Yoshimi T; Nakamura H
Life Sci; 1999; 64(23):2081-8. PubMed ID: 10372650
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cyclic nucleotide phosphodiesterase activity by an endogenous factor.
Ho RJ; Russell TR; Asakawa T; Hucks MW
J Cyclic Nucleotide Res; 1975; 1(2):81-8. PubMed ID: 177458
[TBL] [Abstract][Full Text] [Related]
18. Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea.
Ellis JL; Conanan ND
J Pharmacol Exp Ther; 1995 Mar; 272(3):997-1004. PubMed ID: 7891355
[TBL] [Abstract][Full Text] [Related]
19. On the mechanism of relaxation of tracheal muscle by theophylline and other cyclic nucleotide phosphodiesterase inhibitors.
Fredholm BB; Brodin K; Strandberg K
Acta Pharmacol Toxicol (Copenh); 1979 Nov; 45(5):336-44. PubMed ID: 231892
[TBL] [Abstract][Full Text] [Related]
20. Activation of human lymphocyte high affinity cyclic AMP phosphodiesterase by culture with 1-methyl-3-isobutylxanthine.
Thompson WJ; Ross CP; Hersh EM; Epstein PM; Strada SJ
J Cyclic Nucleotide Res; 1980; 6(1):25-36. PubMed ID: 6155390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
